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ELEVATED LDL CHOLESTEROL-LEVELS DURING EXPERIMENTAL OA
LEADS TO INCREASED SYNOVIAL THICKENING , S100A8/9
PRODUCTION AND ECTOPIC BONE FORMATION
W. de Munter y, M.H. van den Bosch y, A.W. Sloetjes y, T. Vogl z, J. Roth z,
P.M. van der Kraan y, W.B. van der Berg y, P.L. van Lent y. yRadboud Univ.
Med. Ctr., Nijmegen, Netherlands; z Inst. f€ur Immunologie, Muenster,
Germany
Purpose: In a previous study, we showed that LDL accumulation by LDL
receptor deﬁcient mice resulted in increased ectopic bone formation dur-
ing experimental osteoarthritis (OA). Furthermore, we found that S100A8/
A9 proteins are crucial in mediating joint pathology during experimental
OA. In the present study we investigate OA pathology and its correlation
with S100A8/9 in ApoE deﬁcient (ApoE-/-) mice, which is a differentmodel
for studying effects of systemically high LDL cholesterol levels.
Methods: Wild type (WT) and ApoE-/- mice received a normal or cho-
lesterol-rich diet for 54 days. At day 18, experimental OA was induced
by intra-articular injection of collagenase and animals were sacriﬁced at
day 28 and 54. Synovial RNA expression and joint pathology was
investigated by RT-PCR and histology, respectively. LDL and S100A8/9
levels were measured in serum and synovial wash-outs.
Results: ApoE-/- mice on a normal diet showed remarkably higher LDL
levels than WT mice (8.90 mmol/L and 0.40 mmol/L, respectively; p <
0.0001). Experimental OA in ApoE-/- mice showed no increase in
synovial thickening and ectopic bone formation, but a signiﬁcant
increase of cartilage damagewas found in ApoE-/- mice compared toWT
mice at the lateral side of the femoral chondyle (OARSI score 13.7 and
6.8, respectively; p < 0.05). Synovial gene expression of both S100A8
and S100A9 was signiﬁcantly increased in ApoE-/- mice compared to
WTmice (fold increase 1.8 and 1.4, respectively; p< 0.05). Furthermore,
S100A8/S100A9 protein levels of synovial wash-outs was increased in
ApoE-/- mice at day 28 (fold increase 5.8; p < 0.05), which was con-
ﬁrmed by immunohistochemical staining for S100A8.
In addition, we investigated whether a cholesterol-rich diet could
increase joint pathology after induction of OA. A cholesterol-rich diet
increased differences in LDL levels even more (18.4 mmol/L in ApoE-/-
mice versus 1.2 mmol/L in WT mice; p < 0.0001) and already 10 days
after induction of OA, histological differences between the two groups
were observed. Synovial thickening was increased by 400% in ApoE-/-
mice compared toWTmice (p< 0.001) and also ectopic bone formation
in the medial collateral ligament was strongly increased at this early
time point (fold increase 2.7; p< 0.01). Cartilage damage, however, was
comparable to cartilage damage observed in mice on a normal diet.
Again, 36 days after induction of OA, S100A8/S100A9 levels were
strongly increased in ApoE-/- mice, both on protein and gene expression
level and signiﬁcantly correlated with ectopic bone formation. EctopicFigure 1. LDL cholesterol correlates with ectopic bone formation in the
medial collateral ligament in experimental OA. Four representative
microphotographs of the medial side of the knee joint, 36 days after
induction of OA by intra-articular injection of collagenase. Both WT and
ApoE deﬁcient mice received a normal or a cholesterol-rich diet, starting
18 days before induction of OA. Saf O - Fast Green staining.bone formation in the medial collateral ligament at this time point was
massive in ApoE-/- mice on a cholesterol-rich diet (ﬁgure 1).
Conclusions: LDL cholesterol accumulation by ApoE deﬁciency results
in increased S100A8 and S100A9 production by synovial cells. A cho-
lesterol-rich diet further increases this production which correlates
with increased synovial thickening and ectopic bone formation in
experimental OA. This suggests an important role for LDL cholesterol in
developing OA joint pathology.
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WNT AND WISP1 EXPRESSION IN THE SYNOVIUM INDUCES
PRODUCTION OF CARTILAGE-DEGRADING METALLOPROTEINASES
BY SYNOVIAL CELLS
M.H. van den Bosch, A.B. Blom, S.W. Suen, A.E. van Erp, F.A. van de Loo,
E.N. Blaney Davidson, P.M. van der Kraan, P.L. van Lent,
W.B. van den Berg. Radboud Univ. Med. Ctr., NCMLS, Nijmegen,
Netherlands
Purpose: Consequences of synovial activation, seen in many osteo-
arthritis (OA) patients, are largely unknown. The synovium mainly
consists of ﬁbroblasts, macrophages and we see monocytes in the early
phases of our OA models. Previously, we found strongly increased
expression of Wnt2b, Wnt16 and WISP1, a downstream protein of
canonical Wnt signaling, in knee joints in two murine OA models. Wnt
signaling has been implicated in OA incidence through activation of the
b-catenin-dependent canonical Wnt signaling pathway. In the present
study, we investigated the potential of Wnt signaling to increase the
expression of cartilage-degrading enzymes in the synovium.
Methods: Pathway analysis of microarray data from the synovium of a
collagenase-induced OA mouse model was done using DAVID bio-
informatics software. In vivo synovial overexpression of genes from the
Wnt signaling pathway was achieved by intra-articular injection of
adenoviral vectors. Human OA synovial tissue was collected from joint
replacement surgery and either stimulated directly or used for out-
growth of OA ﬁbroblasts. Monocytes were isolated from buffy coats
from healthy donors and stimulated directly or after differentiation into
M1 or M2 macrophages. Joint pathology was assessed by histology.
Gene expression was analyzed by qPCR. Protein expression was meas-
ured in culture supernatants by Luminex.
Results: Pathway analysis showed that Wnt signaling was enriched in
the synovium during experimental OA. To determine the effects of Wnt
signaling on the expression of cartilage-degrading enzymes in synovial
tissue, we stimulated human OA synovial specimen with Wnt3a or its
downstream protein WISP1. This resulted in increased expression of
MMP3, MMP9 and MMP13, whereas expression of the MMP inhibitors
TIMP1 and 3 was not altered. Next, we investigated which cell-type in
the synovium might have caused the increased MMP expression.
Stimulation of human synovial OA ﬁbroblasts with Wnt3a or WISP1
increased the expression of both MMP3 and MMP13, whereas TIMP
expression was not altered. In contrast, stimulation of both M1 and M2
macrophages with either Wnt3a or WISP1 did not result in increased
expression of MMPs. In addition, we stimulated monocytes, which are
present in the synovium in the early phases of our OA mouse models.
Stimulation of primary human monocytes with Wnt3a or WISP1
strongly increased the expression of MMP3, MMP9 and MMP13.
Expression levels of TIMP1 and 3 were not altered. Next, we hypothe-
sized that if increased Wnt signaling was present in OA synovial tissue
and stimulation of synovial tissue with members of the Wnt signaling
pathway increased the expression of MMPs, we should be able to
decrease the expression of MMPs by blocking the Wnt signaling path-
way. Inhibition of Wnt signaling by both FrzB and DKK-1, a speciﬁc
inhibitor for canonical Wnt signaling, led to decreased expression of
MMP3, MMP9 and MMP13 in human synovial specimen.
Finally, to determine if synovial overexpression of members of the Wnt
signaling pathway leads to cartilage damage in vivo, we injected ade-
noviral vectors for Wnt5a, Wnt8a and Wnt16 into murine knee joints.
These vectors speciﬁcally target synovial cells but do not penetrate into
the cartilage, due to their size. Overexpression of Wnt8a and Wnt16 led
to b-catenin accumulation, indicating signaling via the canonical Wnt
signaling pathway, whereas Wnt5a overexpression did not. Seven days
after overexpression, we found a signiﬁcant induction of OA pathology
after overexpression ofWnt8a andWnt16, but notWnt5a, at the medial
margin of the medial tibial plateau, a preferential site for damage in
experimental OA. Lesions were found in 92% (n ¼ 12) of the knee joints
after Wnt8a overexpression compared to 17% (n ¼ 12) for the control
